Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin

  1. Karp, D.D.
  2. Pollak, M.N.
  3. Cohen, R.B.
  4. Eisenberg, P.D.
  5. Haluska, P.
  6. Yin, D.
  7. Lipton, A.
  8. Demers, L.
  9. Leitzel, K.
  10. Hixon, M.L.
  11. Terstappen, L.W.
  12. Garland, L.
  13. Paz-Ares, L.G.
  14. Cardenal, F.
  15. Langer, C.J.
  16. Gualberto, A.
Aldizkaria:
Journal of Thoracic Oncology

ISSN: 1556-1380,  1556-0864

Argitalpen urtea: 2009

Alea: 4

Zenbakia: 11

Orrialdeak: 1397-1403

Mota: Artikulua

DOI: 10.1097/JTO.0B013E3181BA2F1D GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus